| Literature DB >> 29914977 |
Christine Bellanné-Chantelot1,2, Barbara Schmaltz-Panneau2,3, Caroline Marty2,3, Odile Fenneteau4, Isabelle Callebaut5, Séverine Clauin1, Aurélie Docet1, Gandhi-Laurent Damaj6, Thierry Leblanc7, Isabelle Pellier8, Cécile Stoven9, Sylvie Souquere10, Iléana Antony-Debré2,3, Blandine Beaupain11, Nathalie Aladjidi12, Vincent Barlogis13, Frédéric Bauduer14, Philippe Bensaid15, Odile Boespflug-Tanguy16, Claire Berger17, Yves Bertrand18, Liana Carausu19, Claire Fieschi20, Claire Galambrun13, Aline Schmidt21,22, Hubert Journel23, Françoise Mazingue24, Brigitte Nelken24, Thuan Chong Quah25, Eric Oksenhendler20, Marie Ouachée7,18, Marlène Pasquet26, Véronique Saada27, Felipe Suarez28,29,30, Gérard Pierron10, William Vainchenker2,3, Isabelle Plo2,3, Jean Donadieu11,31.
Abstract
Congenital neutropenias (CNs) are rare heterogeneous genetic disorders, with about 25% of patients without known genetic defects. Using whole-exome sequencing, we identified a heterozygous mutation in the SRP54 gene, encoding the signal recognition particle (SRP) 54 GTPase protein, in 3 sporadic cases and 1 autosomal dominant family. We subsequently sequenced the SRP54 gene in 66 probands from the French CN registry. In total, we identified 23 mutated cases (16 sporadic, 7 familial) with 7 distinct germ line SRP54 mutations including a recurrent in-frame deletion (Thr117del) in 14 cases. In nearly all patients, neutropenia was chronic and profound with promyelocytic maturation arrest, occurring within the first months of life, and required long-term granulocyte colony-stimulating factor therapy with a poor response. Neutropenia was sometimes associated with a severe neurodevelopmental delay (n = 5) and/or an exocrine pancreatic insufficiency requiring enzyme supplementation (n = 3). The SRP54 protein is a key component of the ribonucleoprotein complex that mediates the co-translational targeting of secretory and membrane proteins to the endoplasmic reticulum (ER). We showed that SRP54 was specifically upregulated during the in vitro granulocytic differentiation, and that SRP54 mutations or knockdown led to a drastically reduced proliferation of granulocytic cells associated with an enhanced P53-dependent apoptosis. Bone marrow examination of SRP54-mutated patients revealed a major dysgranulopoiesis and features of cellular ER stress and autophagy that were confirmed using SRP54-mutated primary cells and SRP54 knockdown cells. In conclusion, we characterized a pathological pathway, which represents the second most common cause of CN with maturation arrest in the French CN registry.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29914977 PMCID: PMC6536700 DOI: 10.1182/blood-2017-12-820308
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113